Genome Medical Acquires GeneMatters

August 30, 2021

Genome Medical, a South San Francisco–based genomic care delivery company, will acquire GeneMatters, a telehealth genetic counseling and software solutions provider. The deal coincides with Genome Medical's closing of a $60 million Series C financing led by Casdin Capital to accelerate commercial growth and expand technology-enabled genetic services.

Buyers
Genome Medical
Targets
GeneMatters
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.